Multiomic characterization and drug testing establish circulating tumor cells as an ex vivo tool for personalized medicine

Matching the treatment to an individual patient’s tumor state can increase therapeutic efficacy and reduce tumor recurrence. Circulating tumor cells (CTCs) derived from solid tumors are promising subjects for theragnostic analysis. To analyze how CTCs represent tumor states, we established cell line...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jia-Yang, Chou, Hsu-Huan, Lim, Syer Choon, Huang, Yen-Jang, Lai, Kuan-Chen, Guo, Chin-Lin, Tung, Chien-Yi, Su, Chung-Tsai, Wang, Jocelyn, Liu, Edward, Han, Hsiao-Fen, Yeh, Po-Ying, Hu, Chun-Mei, Dunn, Alexander R., Frank, Curtis W., Wu, Yi-Chun, Yang, Muh-Hwa, Chang, Ying-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529671/
https://www.ncbi.nlm.nih.gov/pubmed/36204272
http://dx.doi.org/10.1016/j.isci.2022.105081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529671/
https://www.ncbi.nlm.nih.gov/pubmed/36204272
http://dx.doi.org/10.1016/j.isci.2022.105081

Ejemplares similares